› 6kl6

X-ray diffraction
2.77Å resolution

Crystal structure of MERS-CoV N-NTD complexed with 5-Benzyloxygramine

Released:
DOI: 10.2210/pdb6kl6/pdb
PDB entry 6kl6 coloured by chain, front view.
PDB entry 6kl6 coloured by chain, side view.
PDB entry 6kl6 coloured by chain, top view.
Source organism: Middle East respiratory syndrome-related coronavirus
Primary publication:
Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design.
Lin SM, Lin SC, Hsu JN, Chang CK, Chien CM, Wang YS, Wu HY, Jeng US, Kehn-Hall K, Hou MH
OpenAccess logo J Med Chem 63 3131-3141 (2020)
PMID: 32105468

Function and Biology Details

Biochemical function:
Biological process:
  • not assigned
Cellular component:
Sequence domains:

Structure analysis Details

Assembly composition:
homo dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-125660 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Nucleoprotein Chains: A, B, C, D
Molecule details ›
Chains: A, B, C, D
Length: 144 amino acids
Theoretical weight: 15.86 KDa
Source organism: Middle East respiratory syndrome-related coronavirus
Expression system: Escherichia coli BL21
UniProt:
  • Canonical: K9N4V7 (Residues: 39-165; Coverage: 31%)
Gene names: 6, N
Sequence domains: Coronavirus nucleocapsid

Ligands and Environments

1 bound ligand:
Ligand DJU 1 x DJU
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: SPRING-8 BEAMLINE BL44XU
Spacegroup: P21
Unit cell:
a: 35.489Å b: 108.477Å c: 91.595Å
α: 90° β: 101.16° γ: 90°
R-values:
R R work R free
0.235 0.232 0.271
Expression system: Escherichia coli BL21

Quick links

Citations

20 review citations

COVID-19: Drug Targets and Potential Treatments.
Gil et al. (2020)
19 more

7 mentions without citation

Targeting protein-protein interaction interfaces in COVID-19 drug discovery.
Chang et al. (2021)
6 more